{"schema_version":"secwatch.filing_event.v1","accession":"0001032220-23-000042","form_type":"8-K","ticker":"MMS","cik":"0001032220","company_name":"MAXIMUS, INC.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.691926+00:00","generated_at":"2026-06-15T11:53:30.399978+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Maximus Q2 FY2023 EPS down; reaffirms FY guidance; debt reduced $275M","bullets":["Q2 revenue $1.21B (+2.5% YoY); diluted EPS $0.52, adjusted EPS $0.80 (vs $0.80 and $1.07 prior year).","Operating cash flow $309.7M, free cash flow $291.6M; repaid $275M debt; net debt/EBITDA improved to 2.5x.","Reaffirmed FY23 guidance: revenue $4.85B-$5.0B; adjusted EPS $4.00-$4.30; divested two small non-core businesses.","U.S. Services margin 9.5% (down YoY) due to paused Medicaid redeterminations; expects ramp in Q3/Q4.","Outside the U.S. segment revenue -16% to $173M, operating loss $3.7M; guidance for segment margin lowered to 1-3%."],"urls":{"canonical":"https://secwatch.observer/filing/0001032220-23-000042","json":"https://secwatch.observer/filing/0001032220-23-000042.json","markdown":"https://secwatch.observer/filing/0001032220-23-000042.md","text":"https://secwatch.observer/filing/0001032220-23-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1032220/000103222023000042/0001032220-23-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1032220/000103222023000042/mms-20230503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T11:53:30.399978+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bc954b8463d666301fa0629e4d25599d7e0016cc","claim":"MAXIMUS, INC. reported the three and six months ended March 31, 2023 results: revenue $1.21 billion, EPS $0.52. Guidance reaffirmed.","evidence_excerpt":"reported financial results for the three and six months ended March 31, 2023. Highlights for the second quarter of fiscal year 2023 include: • Revenue increased 2.5% to $1.21 billion, compared to $1.18 billion for the prior year period. Organic growth was 3.9% and driven by new or expanded programs in the U.S. segments. • Diluted earnings per share were","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1032220/000103222023000042/0001032220-23-000042-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended March 31, 2023"},{"label":"Revenue","value":"$1.21 billion"},{"label":"EPS","value":"$0.52"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}